Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Cancer Control : Journal of the Moffitt Cancer Center|October 7, 2011
Hematopoietic cell transplantation for lymphomasErnesto Ayala, Marcie TomblynExpert Review of Anticancer Therapy|June 25, 2003
Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphomaMarcie Tomblyn, Jane N WinterHaematologica|May 14, 2011
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoidsJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.Current Opinion in Hematology|May 27, 2009
Second hematopoietic stem cell transplantation in myeloid malignanciesLisa M Arfons, Marcie Tomblyn, Vanderson Rocha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trialJulie M Vose, Shelly Carter, Linda J Burns, et al.Cancer Control : Journal of the Moffitt Cancer Center|June 20, 2012
Hematopoietic cell transplantation for B-cell lymphoma: an updateErnesto AyalaInternational Journal of Hematology|January 20, 2011
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complicationsJoseph Pidala, Jaime Roman-Diaz, Jongphil Kim, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2011
ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantationJoseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allograftingMohamed A Kharfan-Dabaja, Claudio Anasetti, Hugo F Fernandez, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantationMarcie Tomblyn, Claudio Brunstein, Linda J Burns, et al.Pageof 12